Ayahuasca Protects Brain From Stress, Primate Study Finds

Administering ayahuasca before and during chronic social stress might have prevented cortical atrophy and preserved neuronal volume in common marmosets, according to a peer-reviewed study published in Translational Psychiatry. Researchers found that juvenile primates subjected to isolation experienced significant reductions in brain cell size, while those treated with the psychoactive plant brew maintained structural dimensions comparable to family-housed control groups.

Ayahuasca Stress Study Design and Primate Isolation Methods

According to study author Luiz Roberto Fernandes Pereira and his colleagues, the research utilized six common marmosets (Callithrix jacchus), a small New World monkey species native to northeastern Brazil. These primates are frequently used in scientific inquiries because their brains lack gyri and convolutions, which simplifies the examination of target brain regions. Furthermore, the species is common, reproduces easily, and reaches sexual maturity by 1.5 to 2 years of age.

The six marmosets, aged between 7 and 9 months, were divided into three groups of two: a family group, an isolation group, and an ayahuasca group. All animals lived with their families for the first four weeks. Afterward, the family group remained in social housing for nine weeks, while the isolation and ayahuasca groups were separated and kept in individual cages to induce chronic stress mimicking human depression.

Impact on Neuronal Volume and Somatosensory Cortex Atrophy

Depressive states in humans typically coincide with alterations across multiple brain regions, including a notable 30% loss of dendritic spines in somatosensory neurons that impairs signal processing. To test whether the psychoactive brew mitigates these structural declines, the ayahuasca group received three oral gavage doses of the tea at 1.67 mL per 300 grams of body weight. The first dose was administered three days prior to isolation, with subsequent doses given 25 and 50 days later.

At the conclusion of the experiment, the animals were euthanized using sodium thiopental for tissue examination. Results showed that marmosets in the isolation group suffered a statistically significant reduction in individual neuronal volume compared to the family group. In contrast, the ayahuasca-treated primates maintained neuronal volumes similar to the family group, indicating a protective effect against stress-induced cellular shrinkage.

Pro tip: While preclinical animal studies provide critical insights into neural plasticity, researchers emphasize that findings in non-human primates do not automatically translate to human clinical outcomes.

Evaluating Macrostructural Limits and Statistical Trends

Although the preservation of individual cell size proved statistically significant, the study’s small sample size of only two animals per experimental group prevented researchers from confirming statistical significance regarding overall cortical volume and neuronal density. According to the study authors, macrostructural evaluations require larger cohorts to fully substantiate whole-brain anatomical impacts.

“Although differences in neuronal density and cortical volume could not be statistically confirmed, trends indicated potential preservation of cortical structure in the AG,” the study authors noted in the published paper. They added that these preliminary observations highlight the substance’s potential influence on neural plasticity and stress resilience.

Understanding Ayahuasca Composition and Pharmacology

Traditional ayahuasca is a psychoactive plant brew used for healing and spiritual purposes by indigenous communities in the Amazon region. The preparation typically combines the vine Banisteriopsis caapi with leaves from Psychotria viridis or other plants containing the psychedelic compound dimethyltryptamine (DMT). DMT primarily targets serotonin receptors in the brain, particularly the 5-HT2A receptor.

When ingested orally on its own, digestive monoamine oxidase enzymes break down DMT rapidly. However, the harmala alkaloids present in the Banisteriopsis caapi vine inhibit these enzymes, allowing DMT to remain active and produce psychoactive effects that last several hours. While preliminary research investigates the brew for conditions like depression and addiction, ayahuasca is not an established substitute for standard psychiatric treatment.

Frequently Asked Questions

What is ayahuasca made of?

Traditional ayahuasca is prepared by brewing the Banisteriopsis caapi vine with plant leaves containing DMT, such as Psychotria viridis.

What did the marmoset study discover about stress?

According to the published research, administering ayahuasca to marmosets undergoing chronic social isolation prevented the reduction of individual neuronal volume seen in untreated isolated animals.

Can these results be applied directly to humans?

No. Study authors caution that while humans and marmosets share physiological similarities, the small sample size and species differences mean findings cannot be directly generalized to human medical treatments.

What are the legal and health considerations regarding ayahuasca?

Legal statuses vary globally, and potential health risks depend heavily on the brew’s chemical composition, individual health factors, and the consumption environment.